Novartis | NOVN - Kapitalisasi Pasar





Kapitalisasi Pasar Perubahan Tanggal
AbbVie USD 508.97B 46.71B 2026-11
Alcon AG USD 33.76B 3.29B 2026-06
Almirall EUR 2.76B 472.53M 2025-12
Amgen USD 247.94B 20.06B 2026-11
AstraZeneca USD 213.88B 23.43B 2026-11
Bayer EUR 52.42B 5.31B 2026-11
Biogen USD 33.38B 1.48B 2026-09
Bristol-Myers Squibb USD 127.46B 9.81B 2026-09
Eli Lilly USD 1.09T 40.33B 2026-09
Fresenius EUR 28.94B 6.43B 2026-11
Fresenius Medical Care EUR 11.61B 980.33M 2026-11
Genmab DKK 17.1B 88.06B 2026-06
Gilead Sciences USD 184.82B 27.96B 2026-09
GlaxoSmithKline GBP 74.11B 6.03B 2026-09
GRIFOLS EUR 4.68B 1.1B 2026-11
Hikma Pharmaceutical USD 4.63B 1.42B 2025-12
J&J USD 653.61B 42.25B 2026-09
Lakefront Biotherapeutics EUR 1.73B 2.64M 2026-06
Lonza CHF 39.68B 980.61M 2025-06
Merck EUR 18.98B 27.8B 2026-06
Merck USD 375.59B 17.09B 2026-11
Novartis USD 292.09B 51.5B 2026-09
Novartis USD 328.21B 54.92B 2026-11
Novo Nordisk A/S DKK 1.4T 373.76B 2026-06
Pfizer USD 169.88B 6.47B 2026-11
Philips EUR 23.57B 481.01M 2026-11
Recordati EUR 10.44B 184.5M 2026-06
Roche Holding CHF 270B 3.66B 2026-06
Sanofi EUR 100.56B 13.53B 2026-11
UCB EUR 46.41B 13.94B 2025-12